TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. NVDA
2. ORCL
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,181,653       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,181,653       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.50 +0.03 (1.21%)
Previous Close $2.47    52 Week High $7.79 
Open $2.42    52 Week Low $4.32 
Day High $2.54    P/E N/A 
Day Low $2.42    EPS $-0.36 
Volume 97,635       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.50 +0.03 (1.21%)
Previous Close $2.47    52 Week High $7.79 
Open $2.42    52 Week Low $4.32 
Day High $2.54    P/E N/A 
Day Low $2.42    EPS $-0.36 
Volume 97,635       

Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) Delayed: 18.44 +0.35 (1.93%)
Previous Close $18.09    52 Week High $26.24 
Open $18.40    52 Week Low $18.86 
Day High $18.55    P/E N/A 
Day Low $18.36    EPS $0.00 
Volume 66,998